StonvexLoading…
StonvexStonvexStonvexCore line items from AMH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2019 2019-03-31 | Annual 2018 2018-12-31 | Q3 2018 2018-09-30 | Q2 2018 2018-06-30 |
|---|---|---|---|---|
Revenue | $279.20M | $1.07B | $802.54M | $522.49M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $33.09M | $112.44M | $77.70M | $25.90M |
EPS (Diluted) | $0.05 | $0.08 | $0.05 | $-0.05 |
Total Assets | $9.19B | $9.00B | $8.97B | $8.83B |
Total Liabilities | $3.22B | $3.03B | $2.98B | $2.96B |
Cash & Equivalents | $154.58M | $30.28M | $110.14M | $53.50M |
Free Cash Flow OCF − CapEx | $138.21M | $358.50M | $335.56M | $216.94M |
Shares Outstanding | 297.44M | 294.27M | 293.32M | 290.85M |